Luminescent multiplex viability assay for Trypanosoma brucei gambiense

N. van Reet, P. Pyana, S. Rogé, F. Claes, P. Büscher

    Research output: Contribution to journalA1: Web of Science-article

    8 Downloads (Pure)

    Abstract

    BACKGROUND: New compounds for the treatment of human African trypanosomiasis (HAT) are urgently required. Trypanosoma brucei (T.b.) gambiense is the leading cause of HAT, yet T.b. gambiense is often not the prime target organism in drug discovery. This may be attributed to the difficulties in handling this subspecies and the lack of an efficient viability assay to monitor drug efficacy. METHODS: In this study, a T.b. gambiense strain, recently isolated in the D.R. Congo, was made bioluminescent by transfection with Renilla luciferase (RLuc) without altering its in vitro and in vivo growth characteristics. A luminescent multiplex viability assay (LMVA), based on measurement of the Renilla luciferase activity and the ATP content of the cells within the same experiment, was investigated as an alternative to the standard fluorimetric resazurin viability assay for drug sensitivity testing of T.b. gambiense. RESULTS: In a 96-well format, the RLuc transfected strain showed a detection limit of 2 x 104 cells ml-1 for the Renilla luciferase measurement and 5 x 103 cells ml-1 for the ATP measurement. Both assays of the LMVA showed linearity up to 106 cells ml-1 and correlated well with the cell density during exponential growth of the long slender bloodstream forms. The LMVA was compared to the fluorimetric resazurin viability assay for drug sensitivity testing of pentamidine, eflornithine, nifurtimox and melarsoprol with both the wild type and the RLuc transfected population. For each drug, the IC50 value of the RLuc population was similar to that of the wild type when determined with either the fluorimetric resazurin method or the LMVA. For eflornithine, nifurtimox and melarsoprol we found no difference between the IC50 values in both viability assays. In contrast, the IC50 value of pentamidine was higher when determined with the fluorimetric resazurin method than in both assays of the LMVA. CONCLUSIONS: LMVA has some advantages for viability measurement of T.b. gambiense: it requires less incubation time for viability detection than the fluorimetric resazurin assay and in LMVA, two sensitive and independent viability assays are performed in the same experiment.
    Original languageEnglish
    JournalParasites and Vectors
    Volume6
    Pages (from-to)207
    Number of pages9
    ISSN1756-3305
    DOIs
    Publication statusPublished - 2013

    Keywords

    • Protozoal diseases
    • Sleeping sickness
    • Trypanosomiasis-African
    • Trypanosoma brucei gambiense
    • Vectors
    • Tsetse flies
    • Glossina morsitans
    • Multiplex PCR
    • Assays
    • Viability
    • Strains
    • Sensitivity
    • Bioluminescence
    • Drug sensitivity
    • Testing
    • Pentamidine
    • Eflornithine
    • Nifurtimox
    • Melarsoprol
    • Laboratory techniques and procedures

    Fingerprint

    Dive into the research topics of 'Luminescent multiplex viability assay for <i>Trypanosoma brucei gambiense</i>'. Together they form a unique fingerprint.

    Cite this